Asset
APREPITANT
Heron Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03718039 | phase2 | completed | 2018-10-24 | 2019-01-31 | Heron Therapeutics | Phase 2 Bunionectomy HTX-011 Administration Study |
FDA applications (2)
| Application | Type | Applicant |
|---|---|---|
| NDA 209296 | NDA | HERON THERAPEUTICS INC |
| NDA 216457 | NDA | HERON THERAPEUTICS INC |
Marketed products (2)
- APONVIE
- CINVANTI